Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Review ArticlePractice

Update on age-appropriate preventive measures and screening for Canadian primary care providers

Tawnya Shimizu, Manon Bouchard and Cleo Mavriplis
Canadian Family Physician February 2016; 62 (2) 131-138;
Tawnya Shimizu
Primary Health Care Nurse Practitioner at the Primrose site of the Bruyère Academic Family Health Team in Ottawa, Ont, Adjunct Professor in the Faculty of Medicine at the University of Ottawa, and Therapeutics Tutor and Preceptor in the Ontario Primary Health Care Nurse Practitioner Program.
MN NP-PHC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tshimizu@bruyere.org
Manon Bouchard
Primary Health Care Nurse Practitioner at the Primrose site of the Bruyère Academic Family Health Team and Guest Lecturer and Preceptor for both the Nurse Practitioner Program and the Department of Family Medicine at the University of Ottawa.
NP-PHC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cleo Mavriplis
Family physician at the Primrose site of the Bruyère Academic Family Health Team and Assistant Professor in the Department of Family Medicine at the University of Ottawa.
MD CCFP FCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Sample charting tool for age-appropriate primary prevention maneuvers for women aged 21 to 49 y*: Recommendations with good evidence are presented in boldface; those with fair evidence are presented in italic text; consensus recommendations are presented in plain text. These recommendations are intended for primary care prevention and screening. Additional testing or physical examination, as required, for pre-existing conditions and presenting complaints might be warranted.

    BMI—body mass index; BP—blood pressure; FINDRISC—Finnish Diabetes Risk Score; HbA1c—hemoglobin A1c; HBV—hepatitis B virus; HPV—human papillomavirus; HT—height; MMR—measles-mumps-rubella; STI—sexually transmitted infection; Td—tetanus and diphtheria; Tdap—tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis; VDRL—Venereal Disease Research Laboratory; WC—waist circumference; WT—weight.

    *Additional templates for other age and sex categories are available from CFPlus.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1.

    The 2015 Primrose Preventive Screening Guidelines: Recommendations with good evidence are presented in boldface; those with fair evidence are presented in italic text; consensus recommendations are presented in plain text. These recommendations are intended for primary care prevention and screening. Additional testing or physical examination, as required, for pre-existing conditions and presenting complaints might be warranted.

    MANEUVERRECOMMENDATIONS
    AGE 21–49 YAGE 50–64 YAGE ≥ 65 Y
    History and counseling
      • SubstancesSmoking14
    Alcohol15,16: ≤ 10 drinks/wk for women, ≤ 15 drinks/wk for men
    Other substances17
    Smoking
    Alcohol: ≤ 10 drinks/wk for women, ≤ 15 drinks/wk for men
    Other substances
    Smoking
    Alcohol: ≤ 10 drinks/wk for women, ≤ 15 drinks/wk for men
    Other substances
      • Physical activity150 min/wk moderate or vigorous intensity18 (cannot say more than a few words without pausing for breath)150 min/wk moderate or vigorous intensity (cannot say more than a few words without pausing for breath)150 min/wk moderate or vigorous intensity (cannot say more than a few words without pausing for breath)
      • Diet and nutritionFruit, vegetables, whole grains, healthy fat, ≤ 2000 mg/d of salt19Fruit, vegetables, whole grains, healthy fat, ≤ 2000 mg/d of saltFruit, vegetables, whole grains, healthy fat, ≤ 2000 mg/d of salt
      • Sun exposureProtective clothing, sunscreen20Protective clothing, sunscreenProtective clothing, sunscreen
      • Sexual activitySafe sex and STI counseling21 (Screen for chlamydia and gonorrhea annually until age 25 y if sexually active and beyond age 25 y if high risk)Safe sex and STI counseling if high riskSafe sex and STI counseling if high risk
       • Advance directivesDiscuss once22
       • SupplementsVitamin D: 400–2000 IU/d23
    Calcium: 1000 mg/d from diet24; 1500–2000 mg/d if pregnant or lactating25
    Vitamin D: 1000–2000 IU/d
    Calcium: 1200 mg/d mainly from diet
    Vitamin D: 1000–2000 IU/d
    Calcium: 1200 mg/d mainly from diet
       • Physical examination*BP,26 height, weight, BMI,27 WC28
    If obese (30 kg/m2 ≤ BMI < 40 kg/m2) offer or refer to structured behavioural interventions aimed at weight loss
    BP, height, weight, BMI, WC
    If obese (30 kg/m2 ≤ BMI < 40 kg/m2) offer or refer to structured behavioural interventions aimed at weight loss
    BP, height, weight, BMI, WC
    If obese (30 kg/m2 ≤ BMI < 40 kg/m2) offer or refer to structured behavioural interventions aimed at weight loss
    Investigations and screening tests
      • CognitiveScreen if a family member is concerned29; memory complaints should be evaluated and followed to assess progression
      • FallsAsk about trips or falls in past year or fear of falling30
      • STIGonorrhea and chlamydia31
    VDRL, HIV, and HBV if high risk
    Gonorrhea and chlamydia VDRL, HIV, and HBV if high riskGonorrhea and chlamydia VDRL, HIV, and HBV if high risk
      • Diabetes†Assess HbA1c level if FINDRISC score > 1432Assess HbA1c level if FINDRISC score > 14Assess HbA1c level if FINDRISC score > 14
      • Lipid levels‡Risk assessment32
    Screen men ≥ 40 y
    Risk assessment
    Screen women ≥ 50 y or menopausal
    Risk assessment
      • Vision19–40 y every 10 y33; 41–49 y every 5 y unless high risk (African American, high myopia, diabetes, or hypertension)50–55 y every 5 y; 56–64 y every 3 y unless high risk (African American, high myopia, diabetes, or hypertension)Annually
      • Colon cancerFIT or FOBT every 2 y or flexible sigmoidoscopy every 10 y34FIT or FOBT every 2 y or flexible sigmoidoscopy every 10 y until 75 y
      • OsteoporosisScreen based on risk factorsScreen women and men once > 65 y35
      • Immunizations§Td, Tdap, HPV, MMR
    Pneumococcal, influenza, varicella, polio, meningococcal conjugate36–38
    Td, Tdap, pneumococcal influenza, herpes zoster, varicella, polioTd, Tdap, pneumococcal, influenza, herpes zoster, varicella, polio
    Women
      • Family planningFolic acid: 0.4–1 mg/d at childbearing age39
    Rubella serology40
      • Cervical cancerStart at age 25 y if sexually active,‖ every 3 y if results are normal41Every 3 y if results are normalEvery 3 y if results are normal; stop at age 69 y if 3 normal results in past 10 y
      • Breast cancerMammogram every 2 y42Mammogram every 2 y; stop at age 75 y
    Men
      • AAA screenAbdominal ultrasound once at age 65–75 y in patients who have ever smoked43
    • AAA—abdominal aortic aneurysm; BMI—body mass index; BP—blood pressure; CVD—cardiovascular disease; FINDRISC—Finnish Diabetes Risk Score; FIT— fecal immunochemical test; FOBT—fecal occult blood test; HbA1c—hemoglobin A1c; HBV—hepatitis B virus; HPV—human papillomavirus; MMR—measles-mumps-rubella; STI—sexually transmitted infection; Td—tetanus and diphtheria; Tdap—tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis; VDRL—Venereal Disease Research Laboratory; WC—waist circumference.

    • WC measurements should be as follows:

      • < 94 cm in men and < 80 cm in women of European, sub-Saharan African, Eastern Mediterranean, or Middle Eastern (Arab) descent;

      • < 90 cm in men and < 80 cm in women of South Asian, Japanese, or Chinese descent; and

      • <102 cm in men and < 88 cm in women are currently used for all other backgrounds for clinical purposes, but prevalence should be given using both European and North American cutoff points to allow better comparisons in future epidemiologic studies of populations of Europid descent.

    • From late middle age until ≥ 80 y there is a decline in the volume of subcutaneous fat and a redistribution of fat from subcutaneous to visceral depots. This might make WC risk factors less valid in older patients.

    • FINDRISC rates diabetes risk within the next 10 y:

      • 0–14 points = low to moderate risk (1%–17% chance of developing diabetes within 10 y); recommend not screening for type 2 diabetes.

      • 15–20 points = high risk (33% chance of developing diabetes within 10 y); recommend screening every 3–5 y with assessment of HbA1c.

      • ≥ 21 points = very high risk (50% chance of developing diabetes within 10 y); recommend annual screening with assessment of HbA1c.

    • Risk assessment: use the Framingham score (multiplied by 2 if there is a family history) or use a cardiovascular age calculator (www.cvage.ca).

      • If the Framingham risk score is < 5%, screen every 3–5 y; ≥ 5% repeat screening annually.

      • Screen men ≥ 40 y and women ≥ 50 y or postmenopausal (consider earlier in ethnic groups at increased risk such as South Asian or First Nations patients) or all patients with any of the following, regardless of age: current smoker, diabetes, arterial hypertension, family history of premature CVD, family history of hyperlipidemia, erectile dysfunction, chronic kidney disease, inflammatory disease, HIV, chronic obstructive pulmonary disease, clinical evidence of atherosclerosis or abdominal aneurysm, clinical manifestation of hyperlipidemia, or obesity (BMI > 27 kg/m2).

      • Framingham risk score only validated to age 74 y.

    • The following are the routine adult immunizations for individuals with low risk.

      • Td: primary series for previously unimmunized adults; booster dose every 10 y.

      • Pertussis: 1 dose of acellular pertussis–containing vaccine (Tdap) in adulthood; adults who will be in close contact with infants should be immunized as early as possible.

      • HPV: bivalent (HPV2) or quadrivalent (HPV4) vaccine for women ≤ 26 y; HPV4 vaccine for men ≤ 26 y. Can be given at > 27 y if high risk of exposure.

      • Measles and mumps: 1 dose for susceptible adults born in or after 1970; consider patients born before 1970 to be immune.

      • Rubella: 2 doses for travelers, postsecondary students, military personnel, and health care workers; if vaccine is indicated, pregnant women should be immunized after delivery.

      • Herpes zoster: 1 dose in those ≥ 60 y; those 50–59 years of age can be given 1 dose, but immunity wanes after 5 y.

      • Influenza: encouraged for adults; recommended for those ≥ 65 y.

      • Pneumococcal 23-valent polysaccharide: 1 dose for those ≥ 65 y.

      • Polio: primary series for previously unimmunized adults when a primary series of tetanus and diphtheria toxoid–containing vaccine is being given or with routine tetanus and diphtheria toxoid–containing vaccine booster doses.

      • Varicella: 2 doses in susceptible adults ≤ 49 y; if patients previously received 1 dose they should receive a second dose; 2 doses in adults ≥ 50 y who are known to be seronegative.

      • Meningococcal conjugate: 1 dose in adults ≤ 24 y not immunized in adolescence.

    • ↵‖ Sexual activity includes intercourse and digital or oral sexual activity involving the genital area with a partner of either sex.

Additional Files

  • Figures
  • Tables
  • CFPlus Additional Information

    This data supplement contains 6 charting tools.

    Files in this Data Supplement:

    • Adobe PDF - ChartingTools.pdf
PreviousNext
Back to top

In this issue

Canadian Family Physician: 62 (2)
Canadian Family Physician
Vol. 62, Issue 2
1 Feb 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Update on age-appropriate preventive measures and screening for Canadian primary care providers
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Update on age-appropriate preventive measures and screening for Canadian primary care providers
Tawnya Shimizu, Manon Bouchard, Cleo Mavriplis
Canadian Family Physician Feb 2016, 62 (2) 131-138;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Update on age-appropriate preventive measures and screening for Canadian primary care providers
Tawnya Shimizu, Manon Bouchard, Cleo Mavriplis
Canadian Family Physician Feb 2016, 62 (2) 131-138;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Quality of evidence
    • Main message
    • Conclusion
    • Acknowledgments
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Mise à jour sur la prévention et le dépistage selon l’âge à l’intention des médecins de soins primaires canadiens
  • If you had to choose 1 article to read this month …
  • PubMed
  • Google Scholar

Cited By...

  • Preventive screening in women who have sex with women
  • Delivering screening programmes in primary care: protocol for a scoping and systematic mixed studies review
  • Choosing Wisely Canada
  • Aborder les soins preventifs chez les aines
  • Approach to preventive care in the elderly
  • Response
  • Lifetime Prevention Schedule: a BC initiative
  • If you had to choose 1 article to read this month ...
  • Google Scholar

More in this TOC Section

Practice

  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
  • Is 45 the new 50 in colorectal cancer screening?
Show more Practice

Clinical Review

  • Top studies of 2024 relevant to primary care
  • Approach to steatotic liver disease in the office
  • Foreskin care
Show more Clinical Review

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire